Lyell Immunopharma, Inc. LYEL
9.85
(0.27)
(2.67%)
as of 25 Sep
- Market cap
- $248.0M
- P/E
- 0.0×
Follow LYEL
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (93.28%) | (80.76%) | (86.98%) | (75.75%) |
+8 more TTM periods Free account |
|
| (71.34%) | (63.15%) | (66.06%) | (63.41%) | ||
ROIC |
(539.53%) | (815.53%) | (17,146.38%) | (2,256.68%) | |
Return on Tangible Assets |
(121.69%) | (93.66%) | (111.43%) | (97.78%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(7.48) | (8.01) | (11.22) | (10.76) | |
Free Cash Flow |
(174.87) | (175.33) | (191.71) | (196.62) | |
Capital Expenditures |
(41.61) | (41.53) | (41.69) | (31.60) | |
Piotroski F-Score |
1.00 | 1.00 | 1.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
(30.43%) | (25.36%) | (30.28%) | (25.44%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
579,625.93% | 489,780.65% | 440,763.89% | 378,400.00% | |
Selling, General and Administrative Expense of Revenue |
149,755.56% | 131,109.68% | 125,375.00% | 119,612.20% | |
Share Based Compensation of Revenue |
146,770.37% | 129,354.84% | 116,191.67% | 59,373.17% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.54 | 0.54 | 0.55 | 0.51 | |
Depreciation/Fixed assets |
0.19 | 0.19 | 0.19 | 0.20 | |
Capex/Depreciation |
(7.25) | (6.58) | (6.34) | (4.33) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(5.70) | (6.12) | (8.78) | (9.03) | |
Capex per Share |
(1.78) | (1.90) | (2.44) | (1.73) | |
Capex to Sales |
1,541.26 | 1,339.71 | 1,158.00 | 770.80 | |
Net Profit Margin |
(920,285.19%) | (794,858.06%) | (762,355.56%) | (794,292.68%) |
Columns are period end dates